Cardiovascular and Renal Benefits of Semaglutide

Benefits of Semaglutide

• The American College of Cardiology recommends semaglutide for patients with type 2 diabetes and established cardiovascular disease, as it reduces the risk of major adverse cardiovascular events by 26% 1
• Semaglutide may provide approximately 20% reduction in risk of composite renal outcomes, primarily through reduction in macroalbuminuria, in patients with type 2 diabetes and established cardiovascular disease 1

Risks and Side Effects

• The American College of Cardiology notes that semaglutide is associated with an increased risk of gastrointestinal side effects, including nausea, vomiting, diarrhea, constipation, and abdominal pain, which are typically dose-dependent and more pronounced during initial treatment or dose escalation 2

Relative Contraindications and Precautions

• Patients with severe gastroparesis may experience worsened symptoms due to delayed gastric emptying when taking semaglutide, and should be monitored closely 2
• Prior gastric surgery is a precaution for semaglutide use, and patients should be monitored closely 2
• Diabetic retinopathy requires close monitoring when taking semaglutide, as it may increase the risk of progression 2

Monitoring Recommendations

• Regular monitoring of renal function is recommended, especially in patients with pre-existing kidney disease taking semaglutide 2
• Eye examination prior to initiation of semaglutide is recommended in patients with diabetes, particularly those with existing retinopathy 2
• Monitoring for gallbladder disease is recommended in patients taking semaglutide 2

Special Populations

• Semaglutide can be used with caution in patients with severe renal impairment, with careful monitoring 2
• Patients on oral hormonal contraceptives should consider switching to a non-oral method or adding a barrier method for 4 weeks after initiation and after each dose escalation of semaglutide 2